With a Little Help from My Friends: The Effects of Naloxone Access and Good Samaritan Laws on Opioid-Related Deaths

By Daniel I. Rees, Joseph J. Sabia, Laura Argys, Joshua Latshaw, & Dhaval Dave. Research Briefs in Economic Policy No. 78. June 14, 2017.

Avoiding Medicare’s Pharmaceutical Trap

By Doug Bandow. Policy Analysis No. 556. November 30, 2005.

Treating Doctors as Drug Dealers: The DEA’s War on Prescription Painkillers

By Ronald T. Libby. Policy Analysis No. 545. June 6, 2005.

Health Care Regulation: A $169 Billion Hidden Tax

By Christopher J. Conover. Policy Analysis No. 527. October 4, 2004.

Drug Reimportation: The Free Market Solution

By Roger Pilon. Policy Analysis No. 521. August 4, 2004.

Demonizing Drugmakers: The Political Assault on the Pharmaceutical Industry

By Doug Bandow. Policy Analysis No. 475. May 8, 2003.

How FDA Regulation and Injury Litigation: Cripple the Medical Device Industry

By Charles A. Homsy. Policy Analysis No. 412. August 28, 2001.

Replace FDA Regulation of Medical Devices with Third-Party Certification

By Noel D. Campbell. Policy Analysis No. 288. November 12, 1997.

Wrecking Ball: FDA Regulation of Medical Devices

By Robert Higgs. Policy Analysis No. 235. August 7, 1995.

Compassion vs Control: FDA Investigational-Drug Regulation

By Dale H. Gieringer. Policy Analysis No. 72. May 20, 1986.